1. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):646-54. doi: 
10.1136/jnnp-2013-306799. Epub 2014 Aug 11.

A diagnostic flow chart for POLG-related diseases based on signs sensitivity and 
specificity.

Tchikviladzé M(1), Gilleron M(2), Maisonobe T(3), Galanaud D(4), Laforêt P(5), 
Durr A(6), Eymard B(7), Mochel F(8), Ogier H(9), Béhin A(5), Stojkovic T(5), 
Degos B(10), Gourfinkel-An I(11), Sedel F(8), Anheim M(10), Elbaz A(12), Viala 
K(3), Vidailhet M(13), Brice A(6), Jardel C(14), Lombès A(15).

Author information:
(1)Department of Neurology, AP-HP, GHU Pitié-Salpêtrière, Paris, France INSERM 
CIC9503, GHU Pitié-Salpêtrière, Paris, France.
(2)INSERM U1016, Institut Cochin; CNRS UMR 8104, Paris, France Service de 
Biochimie Métabolique et Centre de Génétique moléculaire et chromosomique, 
AP-HP, GHU Pitié-Salpêtrière, Paris, France UPMC Univ Paris 06, UMR_S975, Paris, 
France.
(3)Department of Neurophysiology and Neuropathology, AP-HP, GHU 
Pitié-Salpêtrière, Paris, France.
(4)Department of Neuroradiology, AP-HP, GHU Pitié-Salpêtrière, Paris, France.
(5)AP-HP, Centre de Référence de pathologie neuromusculaire Paris-Est, Institut 
de Myologie, GHU Pitié-Salpêtrière, Paris, France.
(6)UPMC Univ Paris 06, UMR_S975, Paris, France Department of Genetics, AP-HP, 
GHU Pitié-Salpêtrière, Paris, France INSERM UMR_S975, CRICM; CNRS UMR 7225, 
Paris, France ICM (Brain and Spine Institute) GH Pitié-Salpêtrière, Paris, 
France.
(7)UPMC Univ Paris 06, UMR_S975, Paris, France AP-HP, Centre de Référence de 
pathologie neuromusculaire Paris-Est, Institut de Myologie, GHU 
Pitié-Salpêtrière, Paris, France INSERM UMR_S975, CRICM; CNRS UMR 7225, Paris, 
France.
(8)Department of Genetics, AP-HP, GHU Pitié-Salpêtrière, Paris, France INSERM 
UMR_S975, CRICM; CNRS UMR 7225, Paris, France Neurometabolic Unit, AP-HP, GH 
Pitié-Salpêtrière, Paris, France.
(9)AP-HP, Maladies héréditaires du métabolisme, GH Robert Debré, Paris, France.
(10)Department of Neurology, AP-HP, GHU Pitié-Salpêtrière, Paris, France.
(11)AP-HP, Centre de référence Epilepsies rares, GH Pitié-Salpêtrière, Paris, 
France.
(12)INSERM, CESP, Social and occupational determinants of health, U1018, 
Villejuif, France Université Versailles St-Quentin, UMRS 1018, Villejuif, 
France.
(13)Department of Neurology, AP-HP, GHU Pitié-Salpêtrière, Paris, France INSERM 
UMR_S975, CRICM; CNRS UMR 7225, Paris, France ICM (Brain and Spine Institute) GH 
Pitié-Salpêtrière, Paris, France Neurometabolic Unit, AP-HP, GH 
Pitié-Salpêtrière, Paris, France.
(14)INSERM U1016, Institut Cochin; CNRS UMR 8104, Paris, France Service de 
Biochimie Métabolique et Centre de Génétique moléculaire et chromosomique, 
AP-HP, GHU Pitié-Salpêtrière, Paris, France.
(15)INSERM U1016, Institut Cochin; CNRS UMR 8104, Paris, France Service de 
Biochimie Métabolique et Centre de Génétique moléculaire et chromosomique, 
AP-HP, GHU Pitié-Salpêtrière, Paris, France Université Paris-Descartes-Paris5, 
Paris, France.

OBJECTIVE: Diseases due to mutations of POLG gene, encoding the mitochondrial 
DNA polymerase, are reputed to have very diverse clinical presentations and have 
been proposed to cause up to 25% adult mitochondrial diseases. Our objective was 
the evaluation of the specificity and sensitivity of the signs encountered with 
POLG mutations.
DESIGN: Forty-four patients out of 154 with sequenced POLG gene had mutations 
affecting either one (POLG(+/-) group) or two POLG alleles (POLG(+/+) group). 
Phenotyping included clinical signs, electroneuromyography and brain imaging 
while mitochondrial investigations encompassed muscle histochemistry, 
respiratory chain assays and search for multiple mitochondrial deletions. The 
specificity and sensitivity of the signs associated with POLG mutations were 
analysed by comparison between POLG(+/+) and patients without POLG mutation.
RESULTS: High sensitivity but low specificity was observed with single signs 
such as axonal sensory neuropathy, cerebellar syndrome, movement disorders and 
weakness involving ocular, pharyngeal, axial and/or limb muscles. Specificity 
was increased with combination of previous signs plus psychiatric symptoms, 
cognitive impairment and epilepsy. High specificity and sensitivity was only 
obtained with sensory neuronopathy associated with one of the following signs: 
weakness of ocular, pharyngeal, axial and/or limb muscles. Mitochondrial 
investigations did not suffice for diagnosis. The widespread neuromuscular signs 
were often present since disease onset and were the rule above 50 years of age 
leading to a very low probability of POLG mutations in patients with less than 
three signs and absent sensory neuropathy.
CONCLUSIONS: Phenotypes associated with POLG mutations follow a reproducible 
pattern, which allows establishing a diagnostic flow chart.

Published by the BMJ Publishing Group Limited. For permission to use (where not 
already granted under a licence) please go to 
http://group.bmj.com/group/rights-licensing/permissions.

DOI: 10.1136/jnnp-2013-306799
PMID: 25118206 [Indexed for MEDLINE]